ABT

insider transactions

ABBOTT LABORATORIES — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Cluster buy signal: 3 different insiders made open-market purchases in the last 90 days, totalling $1.3M.

Net shares · 90d

+14.2K

14.2K buy · 0 sell

Net value · 90d

$1.3M

$1.3M in · $0 out

Sentiment · 90d

Net buying

100% buying · 0% selling

Open-market trades · 90d

14.2K buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Buy·P
May 7, 26

John G Stratton

Director

$173.6K

2.0K sh · $86.82

Own +9%
Other·I
Apr 28, 26

Mary K Moreland KEY

EXECUTIVE VICE PRESIDENT

$501.7K

5.3K sh · $94.41
Buy·P
Apr 27, 26

Daniel J Starks

Director

$926.5K

10.0K sh · $92.65

Own +0%
Grant·A
Apr 24, 26

Nita Ahuja

Director

$0

2.3K sh

Own New
Grant·A
Apr 24, 26

Patricia Paola Gonzalez

Director

$0

2.3K sh

Own +33%
Grant·A
Apr 24, 26

Darren W Mcdew

Director

$0

2.3K sh

Own +22%
Grant·A
Apr 24, 26

Claire Babineaux-Fontenot

Director

$0

2.3K sh

Own +43%
Grant·A
Apr 24, 26

Michelle Kumbier

Director

$0

2.3K sh

Own +15%
Grant·A
Apr 24, 26

Michael F Roman

Director

$0

2.3K sh

Own +27%
Grant·A
Apr 24, 26

Sally E. Blount

Director

$0

2.3K sh

Own +7%
Grant·A
Apr 24, 26

Michael O'Grady

Director

$0

5.9K sh

Own New
Grant·A
Apr 24, 26

Michael O'Grady

Director

$0

2.3K sh

Own +43%
Grant·A
Apr 24, 26

John G Stratton

Director

$0

2.3K sh

Own +12%
Grant·A
Apr 24, 26

Kevin T Conroy

Director

$0

2.3K sh

Own +2%
Grant·A
Apr 24, 26

Nancy Mckinstry

Director

$0

2.3K sh

Own New
Grant·A
Apr 24, 26

Nancy Mckinstry

Director

$0

2.3K sh

Own +6%
Grant·A
Apr 24, 26

Daniel J Starks

Director

$0

7.1K sh

Own New
Grant·A
Apr 24, 26

Daniel J Starks

Director

$0

2.3K sh

Own +0%
Buy·P
Apr 23, 26

Philip P Boudreau KEY

EVP AND CFO

$201.3K

2.2K sh · $91.50

Own New
Other·I
Apr 23, 26

Philip P Boudreau KEY

EVP AND CFO

$820.0K

8.9K sh · $92.04
Grant·A
Mar 31, 26

Nita Ahuja

Director

$10.5K

102 sh · $102.67

Own New
Grant·A
Mar 31, 26

Patricia Paola Gonzalez

Director

$33.0K

321 sh · $102.67

Own +6%
Grant·A
Mar 31, 26

Michael F Roman

Director

$37.7K

367 sh · $102.67

Own +6%
Grant·A
Mar 31, 26

Robert J Alpern

Director

$7.8K

76 sh · $102.67

Own +1%
Grant·A
Mar 31, 26

John G Stratton

Director

$39.2K

382 sh · $102.67

Own +3%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 7, 2026	John G Stratton	Director	Buy P	2.0K	+9%	$86.82	$173.6K
Apr 28, 2026	Mary K Moreland KEY	EXECUTIVE VICE PRESIDENT	Other I	5.3K	—	$94.41	$501.7K
Apr 27, 2026	Daniel J Starks	Director	Buy P	10.0K	+0%	$92.65	$926.5K
Apr 24, 2026	Nita Ahuja	Director	Grant A	2.3K	New	—	$0
Apr 24, 2026	Patricia Paola Gonzalez	Director	Grant A	2.3K	+33%	—	$0
Apr 24, 2026	Darren W Mcdew	Director	Grant A	2.3K	+22%	—	$0
Apr 24, 2026	Claire Babineaux-Fontenot	Director	Grant A	2.3K	+43%	—	$0
Apr 24, 2026	Michelle Kumbier	Director	Grant A	2.3K	+15%	—	$0
Apr 24, 2026	Michael F Roman	Director	Grant A	2.3K	+27%	—	$0
Apr 24, 2026	Sally E. Blount	Director	Grant A	2.3K	+7%	—	$0
Apr 24, 2026	Michael O'Grady	Director	Grant A	5.9K	New	—	$0
Apr 24, 2026	Michael O'Grady	Director	Grant A	2.3K	+43%	—	$0
Apr 24, 2026	John G Stratton	Director	Grant A	2.3K	+12%	—	$0
Apr 24, 2026	Kevin T Conroy	Director	Grant A	2.3K	+2%	—	$0
Apr 24, 2026	Nancy Mckinstry	Director	Grant A	2.3K	New	—	$0
Apr 24, 2026	Nancy Mckinstry	Director	Grant A	2.3K	+6%	—	$0
Apr 24, 2026	Daniel J Starks	Director	Grant A	7.1K	New	—	$0
Apr 24, 2026	Daniel J Starks	Director	Grant A	2.3K	+0%	—	$0
Apr 23, 2026	Philip P Boudreau KEY	EVP AND CFO	Buy P	2.2K	New	$91.50	$201.3K
Apr 23, 2026	Philip P Boudreau KEY	EVP AND CFO	Other I	8.9K	—	$92.04	$820.0K
Mar 31, 2026	Nita Ahuja	Director	Grant A	102	New	$102.67	$10.5K
Mar 31, 2026	Patricia Paola Gonzalez	Director	Grant A	321	+6%	$102.67	$33.0K
Mar 31, 2026	Michael F Roman	Director	Grant A	367	+6%	$102.67	$37.7K
Mar 31, 2026	Robert J Alpern	Director	Grant A	76	+1%	$102.67	$7.8K
Mar 31, 2026	John G Stratton	Director	Grant A	382	+3%	$102.67	$39.2K

About ABT insider trading

This page tracks insider transactions for ABBOTT LABORATORIES (ABT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.